Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Moveltipril (Moveltipril calcium) 是一种强效血管紧张素转换酶(ACE)抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 943 | 现货 | ||
5 mg | ¥ 1,920 | 现货 | ||
10 mg | ¥ 3,320 | 现货 | ||
25 mg | ¥ 6,930 | 现货 | ||
50 mg | ¥ 9,530 | 现货 | ||
100 mg | ¥ 12,800 | 现货 | ||
500 mg | ¥ 25,700 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,280 | 现货 |
产品描述 | Moveltipril (Moveltipril calcium) is a potent angiotensin-converting enzyme (ACE) inhibitor.Moveltipril is converted to captopril in the body for action. |
体内活性 | MC-838 (Moveltipril) (0.1, 0.3, 1.0, and 3.0 mg/kg; i.v.; anesthetized dogs) produced a gradual and dose-dependent decline in aortic pressure associated with no marked changes in coronary blood flow, heart rate, and LVdP/dt. MC-838 inhibited selectively the pressor response to angiotensin I in a dose-related manner. The doses of MC-838 to lower mean aortic pressure by 10 mmHg from the pre-drug value were 2.8 mg/kg; MC-838 to cause 50% inhibition of angiotensin I-pressor response were 1.0 mg/kg. When administration of MC-838 (3.0 mg/kg) was repeated three times at 30 intervals, the second and third injections caused no additional hypotension. These results indicate that MC-838 inhibits angiotensin I-conversion and decreases systemic blood pressure slowly and persistently in anesthetized dogs.[2] |
别名 | Moveltipril calcium, MC-838, Altiopril calcium |
分子量 | 398.52 |
分子式 | C19H30N2O5S |
CAS No. | 85856-54-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (125.46 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.5093 mL | 12.5464 mL | 25.0928 mL | 62.7321 mL |
5 mM | 0.5019 mL | 2.5093 mL | 5.0186 mL | 12.5464 mL | |
10 mM | 0.2509 mL | 1.2546 mL | 2.5093 mL | 6.2732 mL | |
20 mM | 0.1255 mL | 0.6273 mL | 1.2546 mL | 3.1366 mL | |
50 mM | 0.0502 mL | 0.2509 mL | 0.5019 mL | 1.2546 mL | |
100 mM | 0.0251 mL | 0.1255 mL | 0.2509 mL | 0.6273 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Moveltipril 85856-54-8 Endocrinology/Hormones RAAS MC838 Moveltipril calcium MC-838 Altiopril calcium MC 838 Inhibitor inhibitor inhibit